QuiVad

Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on August 11, 2026.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 8.43% on August 19, 2021. The shaded band is the year shown above.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
GSA Capital Partners LLP1.30%newAugust 11, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

History of disclosures

437 disclosures on record for this share.
DateFund% of capitalEnd of publication
February 15, 2023Voleon Capital Management LP1.09%still open
February 8, 2023Voleon Capital Management LP1.10%still open
February 3, 2023Voleon Capital Management LP1.09%still open
January 24, 2023Voleon Capital Management LP1.19%still open
January 19, 2023Voleon Capital Management LP1.20%still open
January 18, 2023Voleon Capital Management LP1.19%still open
January 11, 2023Voleon Capital Management LP1.29%still open
January 3, 2023Voleon Capital Management LP1.38%still open
December 30, 2022Voleon Capital Management LP1.48%still open
December 29, 2022Voleon Capital Management LP1.51%still open
December 28, 2022Voleon Capital Management LP1.65%still open
December 23, 2022Voleon Capital Management LP1.78%still open
December 22, 2022Voleon Capital Management LP1.84%still open
December 20, 2022Voleon Capital Management LP1.99%still open
December 16, 2022Voleon Capital Management LP2.00%still open
December 13, 2022Voleon Capital Management LP1.98%still open
December 12, 2022Voleon Capital Management LP2.00%still open
December 7, 2022Voleon Capital Management LP1.93%still open
December 5, 2022Voleon Capital Management LP1.85%still open
November 25, 2022Voleon Capital Management LP1.90%still open
November 24, 2022Voleon Capital Management LP1.89%still open
November 17, 2022Voleon Capital Management LP1.94%still open
November 15, 2022Voleon Capital Management LP1.82%still open
November 14, 2022Voleon Capital Management LP1.46%still open
November 14, 2022Point72 Asset Management LP0.55%still open
November 11, 2022Voleon Capital Management LP1.23%still open
November 11, 2022Point72 Asset Management LP0.66%still open
November 10, 2022Voleon Capital Management LP1.32%still open
November 10, 2022Point72 Asset Management LP0.77%still open
November 9, 2022Voleon Capital Management LP1.41%still open
November 8, 2022Voleon Capital Management LP1.33%still open
October 31, 2022Voleon Capital Management LP1.24%still open
October 28, 2022Voleon Capital Management LP1.18%still open
October 24, 2022Voleon Capital Management LP1.07%still open
October 14, 2022Voleon Capital Management LP1.17%still open
October 11, 2022Point72 Asset Management LP0.91%still open
October 10, 2022Voleon Capital Management LP1.29%still open
October 7, 2022Voleon Capital Management LP1.36%still open
October 6, 2022Point72 Asset Management LP0.82%still open
October 5, 2022Voleon Capital Management LP1.49%still open
September 30, 2022Voleon Capital Management LP1.57%still open
September 30, 2022Point72 Asset Management LP0.70%still open
September 29, 2022Voleon Capital Management LP1.63%still open
September 28, 2022Point72 Asset Management LP0.63%still open
September 27, 2022Voleon Capital Management LP1.78%still open
September 26, 2022Point72 Asset Management LP0.50%still open
September 23, 2022Voleon Capital Management LP1.87%still open
September 22, 2022Voleon Capital Management LP2.03%still open
September 21, 2022Voleon Capital Management LP1.94%still open
September 20, 2022Voleon Capital Management LP2.17%still open

Other companies sold short in Sweden

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/oncopeptides-ab?page=2